ROTARIX ORAL SUSPENSION (ORAL APPLICATOR)

Product Information

Registration Status: Active

ROTARIX ORAL SUSPENSION (ORAL APPLICATOR) is approved to be sold in Singapore with effective from 2009-04-12. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN13743P.

This product contains Human Rotavirus Not less than 10 CCID?/dose (1.5ml) in the form of SUSPENSION. It is approved for ORAL use.

This product is manufactured by GlaxoSmithKline Biologicals s.a. GlaxoSmithKline Biologicals s.a. (Filling) in BELGIUM.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Human Rotavirus

Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank